Cite
HARVARD Citation
Flandre, T. et al. (2022). Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study. Toxicologic pathology. pp. 712-724. [Online].